Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs PPI With Vitamin D or Probiotics for H. Pylori Eradication
NCT07293910Phase 2Recruiting
- Sponsor
- Tanta University
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands, Live Biotherapeutic Products, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vonoprazan, lactobacillus acidophilus, vitamin d in Helicobacter pylori infection, sponsored by Tanta University. Started Feb 2026; status: recruiting.
02
Drugs
vonoprazanlactobacillus acidophilusvitamin d
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07293910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07293910.